# Sutro Biopharma (STRO) — Analyst Forecast

STRO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/stro/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 15, 2026 | Wedbush | Maintained | Outperform | $60.00 |
| Aug 13, 2026 | Wedbush | Maintained | Outperform | $60.00 |
| Aug 13, 2026 | Citizens | Maintained | Market Outperform | $34.00 |
| Jun 11, 2026 | Truist Securities | Initiated Coverage | Buy | $50.00 |
| May 28, 2026 | Barclays | Initiated Coverage | Overweight | $56.00 |
| May 15, 2026 | HC Wainwright & Co. | Maintained | Buy | $50.00 |
| May 15, 2026 | Wedbush | Upgraded | Neutral → Outperform | $60.00 |
| May 15, 2026 | Leerink Partners | Maintained | Outperform | $43.00 |
| Apr 30, 2026 | Mizuho | Initiated Coverage | Outperform | $50.00 |
| Apr 23, 2026 | Citizens | Maintained | Market Outperform | $41.00 |
| Apr 17, 2026 | Citizens | Maintained | Market Outperform | $35.00 |
| Apr 7, 2026 | Leerink Partners | Initiated Coverage | Outperform | $38.00 |
| Mar 25, 2026 | Deutsche Bank | Maintained | Buy | $55.00 |
| Mar 24, 2026 | HC Wainwright & Co. | Upgraded | Neutral → Buy | $28.00 |
| Mar 24, 2026 | Wells Fargo | Upgraded | Equal-Weight → Overweight | $27.00 |
| Jan 20, 2026 | Citizens | Upgraded | Market Perform → Market Outperform | $23.00 |
| Dec 22, 2025 | HC Wainwright & Co. | Maintained | Neutral | $10.00 |
| Aug 12, 2025 | Wells Fargo | Maintained | Equal-Weight | $3.00 |
| Jun 16, 2025 | Piper Sandler | Upgraded | Neutral → Overweight | $2.00 |
| May 19, 2025 | B of A Securities | Maintained | Underperform | $0.80 |

## Frequently Asked Questions

### What is the latest analyst rating on STRO?

On Oct 15, 2026, Wedbush maintained Sutro Biopharma at Outperform with a price target of $60.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).